Cargando…
Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease
Introduction. Recombinant human thyroid stimulating hormone (rhTSH) is approved for preparation of thyroid remnant ablation with radioactive iodine (RAI) in low risk patients with well differentiated thyroid cancer (DTC). We studied the safety and efficacy of rhTSH preparation for RAI treatment of t...
Autores principales: | Wolfson, Robert M., Rachinsky, Irina, Morrison, Deric, Driedger, Al, Spaic, Tamara, Van Uum, Stan H. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763009/ https://www.ncbi.nlm.nih.gov/pubmed/26977148 http://dx.doi.org/10.1155/2016/6496750 |
Ejemplares similares
-
Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer
por: An, Jee Hyun, et al.
Publicado: (2016) -
Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH
por: Tala, H., et al.
Publicado: (2011) -
Acute-on-Chronic Kidney Injury in Thyroid Hormone Withdrawal: A Case with Possible Implications for Radioactive Iodine Planning
por: McAninch, Elizabeth A., et al.
Publicado: (2015) -
Radioactive iodine uptake in hyperthyroid cats after administration of recombinant human thyroid stimulating hormone
por: Oberstadt, Amy E., et al.
Publicado: (2018) -
Effect of withdrawal of thyroid hormones versus administration of recombinant human thyroid-stimulating hormone on renal function in thyroid cancer patients
por: An, Young-Sil, et al.
Publicado: (2023)